Activation of the interferon-inducible (2'-5') oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1

Virology

Volumn 257, Issue 2, 1999, Pages 303-313

  Sharp, Tyson V ^a   Raine, Daniel A ^a   Gewert, Dirk R ^b   Joshi, Bhavesh ^c   Jagus, Rosemary ^c   Clemens, Michael J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b QT Genetics   (United Kingdom)

^c UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; DOUBLE STRANDED RNA; INTERFERON; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN KINASE; RIBONUCLEASE; SYNTHETASE; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CELL GROWTH; ENZYME ACTIVATION; ENZYME BINDING; ENZYME REGULATION; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; RNA BINDING; RNA DEGRADATION; RNA STRUCTURE;

ADENOVIRIDAE; HTLV; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; RNA VIRUSES;

EID: 0033541944     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9689     Document Type: Article

References (65)

1. Baglioni C., Nilsen T. W., Maroney P. A., de Ferra F. Molecular mechanisms of action of interferon. Texas Rep. Biol. Med. 41:1981;471-478.
2. Ball L. A. Induction of 2′5′-oligoadenylate synthetase activity and a new protein by chick interferon. Virology. 94:1979;282-296.
3. Ball L. A. Induction, purification, and properties of 2′5′ oligoadenylate synthetase. Ann. N. Y. Acad. Sci. 350:1980;486-496.
4. Bhat R. A., Thimmappaya B. Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus. J. Virol. 56:1985;750-756.
5. n. Eur. J. Biochem. 179:1989;595-602.
6. Bogerd H. P., Huckaby G. L., Ahmed Y. F., Hanly S. M., Greene W. C. The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements. Proc. Natl. Acad. Sci. USA. 88:1991;5704-5708.
7. Cayley P. J., Davies J. A., McCullagh K. G., Kerr I. M. Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase. Eur. J. Biochem. 143:1984;165-174.
8. Cayley P. J., Knight M., Kerr I. M. Virus-mediated inhibition of the ppp(A2′p)nA system and its prevention by interferon. Biochem. Biophys. Res. Commun. 104:1982;376-382.
9. Chebath J., Benech P., Hovanessian A., Galabru J., Revel M. Four different isoforms of interferon-induced 2′,5′-oligo(A) synthetase identified by immunoblotting in human cells. J. Biol. Chem. 262:1987a;3852-3857.
10. Chebath J., Benech P., Revel M., Vigneron M. Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature. 330:1987b;587-588.
11. Clarke P. A., Schwemmle M., Schickinger J., Hilse K., Clemens M. J. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res. 19:1991;243-248.
12. Clarke P. A., Sharp N. A., Clemens M. J. Translational control by the Epstein-Barr virus small RNA EBER-1. Reversal of the double-stranded RNA-induced inhibition of protein synthesis in reticulocyte lysates. Eur. J. Biochem. 193:1990;635-641.
13. Clemens M. J. The small RNAs of Epstein-Barr virus. Mol. Biol. Rep. 17:1993;81-92.
14. Clemens M. J. Translational Control. 1996;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 139-172.
15. Clemens M. J., Elia A. The double-stranded RNA-dependent protein kinase PKR: Structure and function. J. Interferon Cytokine Res. 17:1997;503-524.
16. Clemens M. J., Laing K. G., Jeffrey I. W., Schofield A., Sharp T. V., Elia A., Matys V., James M. C., Tilleray V. J. Regulation of the interferon-inducible eIF-2 alpha protein kinase by small RNAs. Biochimie (Paris). 76:1994;770-778.
17. Clemens M. J., Williams B. R. Inhibition of cell-free protein synthesis by pppA2′p5′A2′p5′A: A novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell. 13:1978;565-572.
18. Coccia E. M., Romeo G., Nissim A., Marziali G., Albertini R., Affabris E., Battistini A., Fiorucci G., Orsatti R., Rossi G. B. A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology. 179:1990;228-233.
19. Der S. D., Zhou A. M., Williams B. R. G., Silverman R. H. Identification of genes differentially regulated by interferon α, β or γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA. 95:1998;15623-15628.
20. Desai S. Y., Patel R. C., Sen G. C., Malhotra P., Ghadge G. D., Thimmappaya B. Activation of interferon-inducible 2′-5′ oligoadenylate synthetase by adenoviral VAI RNA. J. Biol. Chem. 270:1995;3454-3461.
21. Dingwall C., Ernberg I., Gait M. J., Green S. M., Heaphy S., Karn J., Lowe A. D., Singh M., Skinner M. A., Valerio R. Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA. 86:1989;6925-6929.
22. Elia A., Laing K. G., Schofield A., Tilleray V. J., Clemens M. J. Regulation of the double stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome. Nucleic Acids Res. 24:1996;4471-4478.
23. Ghosh S. K., Kusari J., Bandyopadhyay S. K., Samanta H., Kumar R., Sen G. C. Cloning, sequencing, and expression of two murine 2′-5′-oligoadenylate synthetases: Structure-function relationships. J. Biol. Chem. 266:1991;15293-15299.
24. Glickman J. N., Howe J. G., Steitz J. A. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J. Virol. 62:1988;902-911.
25. Green S. R., Manche L., Mathews M. B. Two functionally distinct RNA-binding motifs in the regulatory domain of the protein kinase DAI. Mol. Cell. Biol. 15:1995;358-364.
26. Gunnery S., Green S. R., Mathews M. B. Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: Relationship between structure and function. Proc. Natl. Acad. Sci. USA. 89:1992;11557-11561.
27. Hartmann R., Norby P. L., Martesen P. M., Jorgensen P., James M. C., Jacobsen C., Moestrup S. K., Clemens M. J., Justesen J. Activation of 2′-5′ oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers. J. Biol. Chem. 273:1998;3236-3246.
28. Hassel B. A., Zhou A., Sotomayor C., Maran A., Silverman R. H. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 12:1993;3297-3304.
29. Hershey J. W. Translational control in mammalian cells. Ann. Revu. Biochem. 60:1991;717-755.
30. Hovanessian A. G. The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J. Interferon Res. 9:1989;641-647.
31. Inoue J., Seiki M., Yoshida M. The second pX product p27 chi-III of HTLV-1 is required for gag gene expression. FEBS Lett. 209:1986;187-190.
32. Inoue J., Yoshida M., Seiki M. Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. Proc. Natl. Acad. Sci. USA. 84:1987;3653-3657.
33. Jacobs B. L., Langland J. O. When two strands are better than one: The mediators and modulators of the cellular responses to double-stranded RNA. Virology. 219:1996;339-349.
34. Katze M. G., DeCorato D., Safer B., Galabru J., Hovanessian A. G. The adenovirus VAI RNA complexes with the p68 protein kinase to regulate its autophosphorylation and activity. EMBO J. 6:1987;689-697.
35. Kerr I. M., Brown R. E. pppA2′p5′A2′p5′A: An inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. USA. 75:1978;256-260.
36. Krieg P. A. Improved synthesis of full-length RNA probe at reduced incubation temperatures. Nucleic Acids Res. 18:1990.
37. Lerner M. R., Andrews M. C., Miller G., Steitz J. A. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA. 78:1981;805-809.
38. Ma Y., Mathews M. B. Structure, function, and evolution of adenovirus-associated RNA: A phylogenetic approach. J. Virol. 70:1996;5083-5099.
39. Maitra R. K., McMillan N. A., Desai S., McSwiggen J., Hovanessian A. G., Sen G., Williams B. R., Silverman R. H. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology. 204:1994;823-827.
40. Manche L., Green S. R., Schmedt C., Mathews M. B. Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol. Cell. Biol. 12:1992;5238-5248.
41. Martinand C., Montavon C., Salehzada T., Silhol M., Lebleu B., Bisbal C. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells. J. Virol. 73:1999;290-296.
42. Mathews M. B., Shenk T. Adenovirus virus-associated RNA and translation control. J. Virol. 65:1991;5657-5662.
43. Mellits K. H., Pe'ery T., Manche L., Robertson H. D., Mathews M. B. Removal of double-stranded contaminants from RNA transcripts: Synthesis of adenovirus VA RNAI from a T7 vector. Nucleic Acids Res. 18:1990;5401-5406.
44. Mordechai E., Kon N., Henderson E. E., Suhadolnik R. J. Activation of the interferon-inducible enzymes, 2′,5′-oligoadenylate synthetase and PKR by human T-cell leukemia virus type I Rex-response element. Virology. 206:1995;913-922.
45. Muesing M. A., Smith D. H., Cabradilla C. D., Benton C. V., Lasky L. A., Capon D. J. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature. 313:1985;450-458.
46. Muesing M. A., Smith D. H., Capon D. J. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell. 48:1987;691-701.
47. O'Reilly D., Miller L. K., Luckow V. A. Baculovirus Expression Vectors: A Laboratory Manual. 1992;W.H. Freeman & Co. New York.
48. Pain V. M. Initiation of protein synthesis in eukaryotic cells. Eur. J. Biochem. 236:1996;747-771.
49. Patel R. C., Sen G. C. Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase. J. Biol. Chem. 267:1992;7671-7676.
50. Pestka S., Langer J. A., Zoon K. C., Samuel C. E. Interferons and their actions. Ann. Revu. Biochem. 56:1987;727-777.
51. Player M. R., Torrence P. F. The 2-5A system: Modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol. Ther. 78:1998;55-113.
52. Rivas C., Gil J., Melková Z., Esteban M., Díaz-Guerra M. Vaccinia virus E3L protein is an inhibitor of the interferon (IFN)-induced 2-5A synthetase enzyme. Virology. 243:1998;406-414.
53. Roy S., Agy M., Hovanessian A. G., Sonenberg N., Katze M. G. The integrity of the stem structure of human immunodeficiency virus type 1 Tat-responsive sequence of RNA is required for interaction with the interferon-induced 68000-Mr protein kinase. J. Virol. 65:1991;632-640.
54. Rysiecki G., Gewert D. R., Williams B. R. Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J. Interferon Res. 9:1989;649-657.
55. Samanta H., Dougherty J. P., Lengyel P. Synthesis of (2′-5′)(A)n from ATP: Characteristics of the reaction catalyzed by (2′-5′)(A)n synthetase purified from mouse Ehrlich ascites tumor cells treated with interferon. J. Biol. Chem. 255:1980;9807-9813.
56. Schroder H. C., Ugarkovic D., Wenger R., Reuter P., Okamoto T., Muller W. E. Binding of Tat protein to TAR region of human immunodeficiency virus type 1 blocks TAR-mediated activation of (2′-5′)oligoadenylate synthetase. AIDS Res. Human Retroviruses. 6:1990;659-672.
57. Schroder H. C., Wenger R., Kuchino Y., Muller W. E. Modulation of nuclear matrix-associated 2′,5′-oligoadenylate metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus. J. Biol. Chem. 264:1989;5669-5673.
58. Schroder H. C., Wenger R., Rottmann M., Muller W. E. Alteration of nuclear (2′-5′)oligoriboadenylate synthetase and nuclease activities preceding replication of human immunodeficiency virus in H9 cells. Biol. Chem. Hoppe-Seyler. 369:1988;985-995.
59. Sen G. C., Lengyel P. The interferon system: A bird's eye view of its biochemistry. J. Biol. Chem. 267:1992;5017-5020.
60. Sharp T. V., Schwemmle M., Jeffrey I., Laing K., Mellor H., Proud C. G., Hilse K., Clemens M. J. Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Res. 21:1993;4483-4490.
61. Sharp T. V., Xiao Q., Justesen J., Gewert D. R., Clemens M. J. Regulation of the interferon-inducible protein kinase PKR and (2′-5′)oligo(adenylate) synthetase by a catalytically inactive PKR mutant through competition for double-stranded RNA binding. Eur. J. Biochem. 230:1995;97-103.
62. Silverman R. H., Jung D. D., Nolan-Sorden N. L., Dieffenbach C. W., Kedar V. P., SenGupta D. N. Purification and analysis of murine 2-5A-dependent RNase. J. Biol. Chem. 263:1988;7336-7341.
63. Toczyski D. P., Matera A. G., Ward D. C., Steitz J. A. The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proc. Natl. Acad. Sci. USA. 91:1994;3463-3467.
64. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 249:1990;505-510.
65. Zhou A., Hassel B. A., Silverman R. H. Expression cloning of 2-5A-dependent RNase: A uniquely regulated mediator of interferon action. Cell. 72:1993;753-765.